MDS Pharma Services Adopts Innovative Technology for Bioanalysis

KING OF PRUSSIA, PA, June 2 /CNW/ - MDS Pharma Services, a leading provider of innovative drug discovery and development solutions, now offers its bioanalysis clients the benefits of electrochemiluminescent assay (ECLA) testing, with the recent installation and validation of two state-of-the-art instruments at its laboratory in Montreal.

MORE ON THIS TOPIC